Chimeric Antigen Receptor T Cell Therapy for Pediatric B-ALL: Narrowing the Gap Between Early and Long-Term Outcomes

Overview of attention for article published in Frontiers in immunology, August 2020

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 7 Dimensions

Readers on

mendeley: 51 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 7 publications that cite this research output.

7

The most recent citing publications are shown below. View all 7 publications that cite this research output on Dimensions.

The Current State of Chimeric Antigen Receptor T Cell Therapy for B Lymphoblastic Leukemia

Article in Hematology/Oncology Clinics of North America (July 2023)

Suivi immunologique des patients traités par cellules CAR-T pour hémopathie maligne: recommandations du groupe CARTi et de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC)

Article in Bulletin du Cancer (July 2021)

Humanized CD19-Targeted Chimeric Antigen Receptor (CAR) T Cells in CAR-Naive and CAR-Exposed Children and Young Adults With Relapsed or Refractory Acute Lymphoblastic Leukemia

Article in Journal of Clinical Oncology (June 2021)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.